Sangamo Therapeutics
SGMO
#10600
Rank
S$39.38 M
Marketcap
S$0.09506
Share price
0.00%
Change (1 day)
-85.69%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$34.55 Million. In 2025 the company made an earning of -S$0.14 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion2.1%
2025 -S$0.14 Billion9.71%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.26 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$99.11 Million36.89%
2017 -S$72.4 Million-22.32%
2016 -S$93.21 Million54.86%
2015 -S$60.19 Million75.62%
2014 -S$34.28 Million0.13%
2013 -S$34.23 Million
2011 -S$46.02 Million43.66%
2010 -S$32.04 Million28.52%
2009 -S$24.93 Million-23.55%
2008 -S$32.6 Million2.45%
2007 -S$31.82 Million19.5%
2006 -S$26.63 Million50.78%
2005 -S$17.66 Million75%
2004 -S$10.1 Million-33.25%
2003 -S$15.12 Million-62.27%
2002 -S$40.08 Million102.82%
2001 -S$19.76 Million23.21%
2000 -S$16.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.04 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.19 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$0.57 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$0.55 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$3.26 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.63 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.56 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$56.08 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA